Related Experiment Video
Updated: Jan 27, 2026

The Use of Mouse Splenocytes to Assess Pathogen-associated Molecular Pattern Influence on Clock Gene Expression
Published on: July 24, 2018
The Nuclear Receptor and Clock Repressor Rev-erbα Suppresses Myogenesis
Somik Chatterjee1, Hongshan Yin1,2, Weini Li3
1Center for Diabetes Research, Department of Medicine, Houston Methodist Research Institute, Houston, TX, 77030, USA.
Abstract:
Rev-erbα is a ligand-dependent nuclear receptor and a key repressor of the molecular clock transcription network. Accumulating evidence indicate that the circadian clock machinery governs diverse biological processes in skeletal muscle, including muscle growth, repair and mass maintenance. The physiological function of Rev-erbα in myogenic regulation remains largely unknown. Here we show that Rev-erbα exerts cell-autonomous inhibitory effects on proliferation and differentiation of myogenic precursor cells, and these actions concertedly inhibit muscle regeneration in vivo. Mechanistic studies reveal Rev-erbα direct transcriptional control of two major myogenic mechanisms, proliferative pathway and the Wnt signaling cascade. Consistent with this finding, primary myoblasts lacking Rev-erbα display significantly enhanced proliferative growth and myogenic progression. Furthermore, pharmacological activation of Rev-erbα activity attenuates, whereas its inhibition by an antagonist promotes these processes. Notably, upon muscle injury, the loss-of-function of Rev-erbα in vivo augmented satellite cell proliferative expansion and regenerative progression during regeneration. Collectively, our study identifies Rev-erbα as a novel inhibitory regulator of myogenic progenitor cell properties that suppresses postnatal myogenesis. Pharmacological interventions to dampen Rev-erbα activity may have potential utilities to enhance regenerative capacity in muscle diseases.
Insights
Rev-erbα (Rev-erb alpha) inhibits muscle stem cell growth and regeneration. Dampening Rev-erbα activity may enhance muscle repair in diseases.
Area of Science:
- Molecular biology
- Cell biology
- Physiology
Background:
- The circadian clock regulates skeletal muscle processes like growth and repair.
- Rev-erbα is a key repressor in the molecular clock network.
- The role of Rev-erbα in muscle stem cell regulation is largely unknown.
Purpose of the Study:
- To investigate the function of Rev-erbα in myogenic precursor cells and muscle regeneration.
- To elucidate the molecular mechanisms by which Rev-erbα regulates myogenesis.
- To explore the therapeutic potential of modulating Rev-erbα activity for muscle disorders.
Main Methods:
- Cell-autonomous assays on myogenic precursor cells.
- In vivo studies of muscle regeneration following injury.
- Analysis of transcriptional control of myogenic pathways.
- Pharmacological manipulation of Rev-erbα activity.
Main Results:
- Rev-erbα inhibits proliferation and differentiation of myogenic precursor cells.
- Rev-erbα directly represses the proliferative pathway and Wnt signaling in myogenesis.
- Loss of Rev-erbα enhances myoblast proliferation and muscle regeneration.
- Pharmacological inhibition of Rev-erbα promotes myogenic processes.
Conclusions:
- Rev-erbα acts as a novel inhibitory regulator of myogenic progenitor cell properties.
- Rev-erbα suppresses postnatal myogenesis and muscle regeneration.
- Targeting Rev-erbα activity offers a potential strategy for enhancing muscle regeneration in disease states.
More Related Videos
09:38Identification of Nucleolar Factors During HIV-1 Replication Through Rev Immunoprecipitation and Mass Spectrometry
Published on: June 26, 2019
09:17Minimally Invasive Muscle Embedding MIME - A Novel Experimental Technique to Facilitate Donor-Cell-Mediated Myogenesis
Published on: August 24, 2017
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Nuclear Export of mRNA
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists